{
    "clinical_study": {
        "@rank": "13281", 
        "brief_summary": {
            "textblock": "To test the AggreGuide A-100 AA Assay's effectiveness for detecting aspirin induced platelet\n      dysfunction."
        }, 
        "brief_title": "AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Platelet Dysfunction Due to Aspirin Ingestion", 
        "condition_browse": {
            "mesh_term": "Blood Platelet Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  over 18\n\n        Exclusion Criteria:\n\n          -  on aspirin in prior week\n\n          -  medical history of platelet disorders\n\n          -  contraindications to aspirin"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "aspirin na\u00efve subjects over 18"
            }
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01915407", 
            "org_study_id": "AGD 051"
        }, 
        "intervention_browse": {
            "mesh_term": "Aspirin"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 1, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Houston", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "77099"
                }, 
                "name": "Aggredyne, Inc."
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "PAI is the proprietary reporting unit of the Aggreguide.  It is related to the amount of platelet aggregation in the sample of whole blood.", 
            "measure": "Platelet Activity Index (PAI) before and after ingestion of aspirin", 
            "safety_issue": "No", 
            "time_frame": "2 - 30 hours post aspirin ingestion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01915407"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Aggredyne, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Aggredyne, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}